Sign Up
OverviewAPI
The global oncology drugs market is set to expand at an 11.53% CAGR, estimated to hit $474.06 billion by 2030. Key drivers entail the surge in cancer cases, treatment advancements, and increased tobacco use. Major pharmaceutical players, such as Bristol Myer Squibb and GlaxoSmithKline, are actively pursuing R&D and engaging in substantial M&A activities.

Ask a question